GlobeNewswire

Canada's CoinField cryptocurrency exchange going international with commission-free trading app moonGO through a new partnership

Dela

moonGO(TM) app is the fastest and most reliable way to buy/sell and store cryptocurrencies. The app allows users to convert cryptos directly to EUR/USD to be loaded into their moonGo(TM) card and be used anywhere worldwide whether they're shopping online or spending it at a physical retailer who accepts credit cards.

VANCOUVER, British Columbia, July  23, 2018  (GLOBE NEWSWIRE) -- CoinField, the most advanced cryptocurrency exchange in Canada is now extending its services worldwide thanks to a new partnership with Malta's Manticore Ventures to create moonGO(TM), a powerful app designed for traders who thrive on agility, flexibility and security.

With moonGO(TM), users can set up their trading accounts in about 60 seconds, withdraw fiat currency as Euro or US dollars in the form of moonGO(TM) cards, and use the moonGO(TM) cards to make purchases online or at any retailer that accepts credit cards. The moonGO(TM) app will take CoinField's sterling reputation outside of Canada and make its services available to every country in the world except the US and the nations on the US/UN sanction list (Iran, Syria, Sudan, Cuba, North Korea, Burma, Côte d'Ivoire).

"Our vision is to bring the cryptocurrency to people's lives in the most convenient and simple way, and make it available to well-qualified traders in most countries worldwide," CoinField CEO Babak Bob Ras said. "While the users benefit from commission-free trading, they can also convert their assets to fiat at anytime and spend it anywhere in the world through our moonGO(TM) cards. Everyone deserves to have access to blockchain technology. There are many people who want to be part of this revolution, but until now it was not easy for them to enter."

The app offers commission-free buy/sell transactions for popular cryptocurrencies including: Bitcoin, Ethereum, Ripple, Dash, Litecoin, Bitcoin Cash, Bitcoin Gold, Select ERC20 coins & non-ERC20.

But moonGO(TM) goes beyond the exchange of cryptocurrencies. It allows users to withdraw their funds in Euros or US dollars using moonGO(TM) virtual cards. These cards can be added to their Apple Pay, Google Pay, or Samsung Pay accounts. Users can also withdraw their digital assets to their wallets outside the platform at any time.

Just as impressive is the app's reduction of the verification and Know Your Customer (KYC) process from 4-6 weeks to mere seconds thanks to CoinField's multi-algorithm solution. While the approval time may have dropped, the commitment to our Anti-money Laundering policy is as vigilant as ever.  moonGO(TM) employs a very strict AML/KYC policy to fight money laundering activities. Company executives toe a strong line on corruption in cryptocurrency, stating: "Any and all attempts to hurt our traders and tarnish the perception of the revolutionary blockchain technology will be met with the full force of our cutting-edge security infrastructure."

moonGO(TM) will enforce that statement by actively and voluntarily filing reports with regulatory and enforcement agencies that ensure a safe, legal, and secure trading experience for all users.

Among moonGO(TM)'s additional layers of security is the new Secret Vault technology: a virtual "safe" storing sensitive information behind a virtual cloud with a hidden location. The app also features Multi-Signature Wallets that require signatures from multiple peers to ensure legitimacy; DDoS Protection by Cloudflare; Isolated Server Access; and Suspicious Activity Logger. All of these components unite to create a hack-proof trading ecosystem.

Timeline

  • Currently in Phase One, moonGO(TM) is available only to users who register their email addresses for an "Early Access Invite". Early access registration is currently open at https://www.moongo.com
  • moonGO(TM) will launch its alpha version in Q4 2018 with a maximum of 250,000 users from the aforementioned Phase One email registration.
  • The moonGO(TM) app will be available to the public in Q1 2019.
  • CoinField and Manticore hope to bring moonGO(TM) to the US market during fiscal year 2019.

CoinField is Canada's most advanced trading platform, owned and operated by Central Crypto Exchange Corp in Vancouver, Canada. More information can be found at https://www.coinfield.com. moonGO(TM) is 100% owned by Malta's Manticore Ventures Ltd. Manticore is a VC group focused on Fintech and Blockchain technology projects. More information about moonGO(TM) app can be found at https://www.moongo.com.

Contact:
Company: Central Crypto Exchange Corp.  Manticore Ventures Ltd.
E-mail: press@coinfield.com
https://www.coinfield.com
https://www.moongo.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: CoinField via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07Pressmeddelande

PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr

Stillfront Group announces Head of M&A19.12.2018 12:07Pressmeddelande

PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum